Academic Journal
92MO Sotorasib (Soto) + panitumumab (Pmab) and FOLFIRI in previously treated KRASG12C-mutated metastatic colorectal cancer (mCRC): Safety and efficacy for CodeBreaK 101 phase Ib expansion cohort
| العنوان: | 92MO Sotorasib (Soto) + panitumumab (Pmab) and FOLFIRI in previously treated KRASG12C-mutated metastatic colorectal cancer (mCRC): Safety and efficacy for CodeBreaK 101 phase Ib expansion cohort |
|---|---|
| المؤلفون: | Masuishi, T., Strickler, J.H., Machiels, J-P., Hong, D.S., Greil, R., Chan, E., Hippenmeyer, J., Saportas, Y., Cardona, P., Xia, C., Kuboki, Y. |
| المساهمون: | Amgen |
| المصدر: | Annals of Oncology ; volume 34, page S1505 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.10.227 |
| الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2023.10.227 https://api.elsevier.com/content/article/PII:S0923753423044332?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753423044332?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
| رقم الانضمام: | edsbas.57B692FA |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.10.227 |
|---|